Cytoplasmic OPN in glioblastoma biopsies, high OPN in serum from glioblastoma patients, and high OPN in plasma from glioblastoma patients were all associated with poor patient prognosis [14,15,16]. This evidence concerns the gene SPP1 and glioblastoma.